| 000 | 01513 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515201452.0 | ||
| 264 | 0 | _c20100416 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1873-264X | ||
| 024 | 7 |
_a10.1016/j.jpba.2009.11.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonnella, N C | |
| 245 | 0 | 0 |
_aStudy and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical and biomedical analysis _cApr 2010 |
||
| 300 |
_a1047-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAzepines _xchemistry |
| 650 | 0 | 4 | _aCrystallization |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aPowder Diffraction |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aWater _xchemistry |
| 700 | 1 | _aSmoliga, John A | |
| 700 | 1 | _aCampbell, Scot | |
| 700 | 1 | _aBusacca, Carl A | |
| 700 | 1 | _aCerreta, Michael | |
| 700 | 1 | _aVarsolona, Richard | |
| 700 | 1 | _aNorwood, Daniel L | |
| 773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 51 _gno. 5 _gp. 1047-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2009.11.012 _zAvailable from publisher's website |
| 999 |
_c19399650 _d19399650 |
||